(Health-NewsWire.Net, August 26, 2016 ) With the sustained economic development and the improvements in diet, Chinese peoples blood fat level rises too. Many local epidemiological studies on blood fat have proved that a conservative estimate of the incidence of hyperlipemia is 7%-8% while the actual incidence might be above 10%. Over 100 million people in China have to receive cholesterol-lowering therapy, more so with the coming ageing society. As people increasingly pay attention to health, cholesterol-lowering drugs will become more and more promising. The annual market size of statin drug is estimated to surpass USD 20 billion around the world, growing at an annual rate of 20% . Request sample at : https://marketreportscenter.com/request-sample/133419
Simvastatin, a new generation of HMG-COA reductase inhibitor produced by restructuring lovastatin, was introduced into China by MSD (China) in 1995. Domestic simvastatin was developed by Sichuan Industrial Institute of Antibiotics. Simvastatin develops fast after entering China, sales value being CNY 104 million in 2005 and CNY 197 million in 2010. However, later, its sales began to drop to CNY 156 million in 2014. Hangzhou MSD Pharmaceutical Co., Ltd, Merck Sharp & Dohme (UK), Guangzhou Nanxin Pharmaceutical Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Shandong Lukang Pharmaceutical Co., Ltd occupy the majority of market, among which Hangzhou MSD Pharmaceutical Co., Ltd has the largest market share of 39% for sales value in 2014. The sales value of simvastatin will stay at a certain level in a given period despite a downtrend in recent years.
Check for Discount at : https://marketreportscenter.com/request-discount/133419 Readers can get at least the following information from this report: -market size of simvastatin in China -price of simvastatin in China -market outlook of simvastatin in China
The author suggests the following groups of people purchase this report: - manufacturers of lipid-lowering drugs -investors/ research institutions interested in Chinese medicine market -any interest in the Chinese medicine market, please contact CRI for customized survey service
Browse full report with TOC : https://marketreportscenter.com/reports/133419/investigation-report-on-china-simvastatin-market-2010-2019
Connect for more details: Sam Collins Market Reports Center Call us : 1-646-883-3044 (US) Email : info@marketreportscenter.com visit our website : https://marketreportscenter.com
Market Reports Center
Sam Collins
1-646-883-3044
sam@marketreportscenter.com
Source: EmailWire.Com
|